Devices › Device types
FDA product code MUZ · class 3 · Unknown
Stimulator, autonomic nerve, implanted (depression): medical device reports filed with FDA
2,368 reports carry this product code, 2004–2026; 24 brands with a page.
- 2,368
- reports with this product code
- 0% of all MAUDE reports
- 37
- reports, 12 months to August 2026
- 62 in the 12 months before
- 48.9%
- classified as malfunction
- 62.3% across all reports
- 3.3%
- classified as death, as reported
- 0.9% across all reports
Product code MUZ is FDA's classification for "Stimulator, autonomic nerve, implanted (depression)" (unknown panel), a class 3 device. 2,368 medical device reports carry this product code, 0% of the MAUDE database, from August 2004 to August 2026.
37 reports arrived in the 12 months to August 2026, down 40% from 62 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (48.9%), injury (47.2%) and death (3.3%). 24 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Pulse Gen Model 102 | 714 | 14 | 12.2% | 25.8% |
| Lead Model 302 | 358 | 136 | 0% | 91.9% |
| Programming Software | 316 | 1 | 0% | 99.3% |
| Symmetry Gen Model 8103 | 197 | 23 | 3.8% | 22.5% |
| Pulse Gen Model 103 | 96 | 34 | 8.5% | 29.8% |
| Pulse Gen Model Unk | 74 | 7 | 13.6% | 25.8% |
| Bipol Lead Model 300 | 69 | 12 | 0.1% | 92.7% |
| Lead Model 304 | 67 | 272 | 0.1% | 74.2% |
| Programming Wand | 51 | 0 | 0% | 99.7% |
| Pulse Gen Model 106 | 38 | 144 | 5.1% | 39.6% |
| Pulse Gen Model 105 | 32 | 7 | 6.7% | 32.5% |
| Pulse Gen Model 1000 | 31 | 549 | 5.7% | 38.9% |
| Lead Model 303 | 26 | 28 | 0% | 66.5% |
| Lead Model Unknown | 20 | 46 | 1.6% | 83.4% |
| Vns Therapy Pulse | 19 | 0 | 10.7% | 18.3% |
| Ncp Bipolar Lead | 17 | 0 | 0% | 83.5% |
| Bipol Lead Model 302 | 16 | 0 | 0% | 81.5% |
| Pulse Gen Model 101 | 13 | 0 | 12.6% | 41.8% |
| Pulse Gen Model unknown | 13 | 40 | 10.9% | 22.1% |
| Lead Model Unk | 8 | 0 | 0.3% | 80.6% |
| Pulse Gen Model 102r | 7 | 0 | 10.9% | 26.6% |
| Pulse Gen Model 104 | 5 | 4 | 9% | 35% |
| Lead Model 300 | 4 | 22 | 0% | 93.9% |
| Vns Therapy Lead | 4 | 0 | 0% | 50.2% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Cyberonics | 1,569 | 66.3% |
| Livanova USA | 527 | 22.3% |
| Cyberonics - Houston | 244 | 10.3% |
| Houston | 21 | 0.9% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| High impedance | 294 | 12.4% |
| Insufficient device problem information | 263 | 11.1% |
| Device remains implanted | 253 | 10.7% |
| Fracturea broken bone | 114 | 4.8% |
| Explanted | 83 | 3.5% |
| Device operates differently than expectedthe device behaved unexpectedly | 81 | 3.4% |
| Failure to interrogate | 68 | 2.9% |
| Use of incorrect control/treatment settings | 63 | 2.7% |
| Replace | 56 | 2.4% |
| No display/image | 49 | 2.1% |
| Battery problema problem with the battery | 40 | 1.7% |
| Repair | 37 | 1.6% |
| Programming issue | 34 | 1.4% |
| Communication or transmission problemthe device could not communicate or transmit | 33 | 1.4% |
| Device displays incorrect message | 33 | 1.4% |
| Migration or expulsion of device | 32 | 1.4% |
| Computer failure | 22 | 0.9% |
| Device inoperablethe device could not be used | 22 | 0.9% |
| Failure of device to self-test | 22 | 0.9% |
| Premature discharge of battery | 20 | 0.8% |
Questions about stimulator, autonomic nerve, implanted (depression) reports
What is product code MUZ?
FDA's classification code for "Stimulator, autonomic nerve, implanted (depression)", class 3, reviewed by the unknown panel. Every device report carries the product code of the device involved.
How many reports carry this code?
2,368 reports through August 2026, 37 of them in the latest 12 months.
Which brands appear most often?
Pulse Gen Model 102 (714), Lead Model 302 (358), Programming Software (316), Symmetry Gen Model 8103 (197) and Pulse Gen Model 103 (96). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.